Adicet Bio Inc Working Capital to Net Assets Ratio
Adicet Bio Inc working capital to net assets ratio. Adicet Bio Inc (ACET) has a Working Capital to Net Assets ratio of 85.5% as of June 2026. Working capital of $102.76 Million (current assets of $120.76 Million minus current liabilities of $18.00 Million) is measured against net assets of $120.14 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Adicet Bio Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Adicet Bio Inc (2008–2025)
Working capital to net assets ratio of Adicet Bio Inc from 2008 to 2025. This chart shows how Adicet Bio Inc's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 85.5%, reflecting working capital of $102.76 Million against net assets of $120.14 Million USD. See ACET defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Adicet Bio Inc Working Capital to Net Assets Ratio by Year (2008–2025)
Adicet Bio Inc working capital to net assets ratio by year from 2008 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Adicet Bio Inc from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Adicet Bio Inc total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 87.6% | $139.40 Million | $159.21 Million | $160.93 Million | $21.53 Million | ▲ +1.4 pp |
| 2024 | 86.1% | $160.74 Million | $186.61 Million | $180.14 Million | $19.39 Million | ▲ +2.1 pp |
| 2023 | 84.0% | $142.99 Million | $170.18 Million | $162.27 Million | $19.29 Million | ▲ +1.5 pp |
| 2022 | 82.6% | $241.33 Million | $292.34 Million | $261.04 Million | $19.71 Million | ▼ -5.2 pp |
| 2021 | 87.8% | $266.12 Million | $303.13 Million | $282.44 Million | $16.32 Million | ▲ +16.9 pp |
| 2020 | 70.9% | $77.86 Million | $109.83 Million | $100.34 Million | $22.48 Million | ▲ +152.6 pp |
| 2019 | -81.7% | $49.32 Million | $-60.37 Million | $64.19 Million | $14.87 Million | ▼ -181.3 pp |
| 2018 | 99.6% | $103.82 Million | $104.20 Million | $109.53 Million | $5.72 Million | ▲ +1.6 pp |
| 2017 | 98.1% | $48.72 Million | $49.69 Million | $54.23 Million | $5.50 Million | ▲ +14.7 pp |
| 2016 | 83.4% | $253.75 Million | $304.44 Million | $352.66 Million | $98.91 Million | ▲ +10.5 pp |
| 2015 | 72.9% | $185.31 Million | $254.21 Million | $310.31 Million | $125.00 Million | ▲ +5.3 pp |
| 2014 | 67.6% | $157.83 Million | $233.58 Million | $276.35 Million | $118.52 Million | ▲ +1.6 pp |
| 2013 | 66.0% | $128.39 Million | $194.64 Million | $218.30 Million | $89.91 Million | ▼ -4.5 pp |
| 2012 | 70.4% | $118.33 Million | $168.00 Million | $191.97 Million | $73.64 Million | ▼ -9.6 pp |
| 2011 | 80.1% | $115.43 Million | $144.15 Million | $198.62 Million | $83.19 Million | ▼ -17.2 pp |
| 2010 | 97.2% | $120.92 Million | $124.35 Million | $195.55 Million | $74.63 Million | ▼ -2.2 pp |
| 2009 | 99.5% | $124.71 Million | $125.38 Million | $171.65 Million | $46.94 Million | ▼ -4.7 pp |
| 2008 | 104.1% | $128.79 Million | $123.67 Million | $193.78 Million | $65.00 Million | — |